WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (NASDAQ:OSCI - News) will participate in the Massachusetts Biotechnology Council’s 9th Annual MASS Opportunities Investment Conference on Thursday, November 8, 2007 in Boston. The Company’s Executive Vice President, Nick Colangelo, will provide an overview of the Company including details on the market performance of ANTARA® (fenofibrate) capsules and the launch of FACTIVE® 5 (gemifloxacin mesylate) tablets in the U.S.
